Results for “ ”

Entry Author Date Location
Sanofi Adds mRNA COVID-19 Vaccine Bet Through Translate Bio Alliance 03/27/20 Europe
Equillium Continues Graft-Versus-Host Disease Trial, Pauses 2 Others 03/27/20 San Diego
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Fusion Pharmaceuticals Taps James O’Leary as Chief Medical Officer 03/26/20 Boston
Akcea Therapeutics Promotes Damien McDevitt to CEO 03/26/20 Boston
Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections 03/26/20 San Diego
With $80M, ReCode Looks to Advance RNA Therapies for Lung Diseases 03/26/20 San Francisco
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch 03/26/20 New York
Oncology Needs Combo Therapies & More Data Analysis, Says Bio-Europe Spring Panel 03/26/20 Boston
Regenacy Pharma Raises $30M for Nerve Function Restoring Treatments 03/25/20 Boston
AstraZeneca Joins RNAi Mix, Pledging $80M to Silence Therapeutics 03/25/20 Europe
Kallyope Gains $112M to Move “Gut-Brain Axis” Programs to the Clinic 03/25/20 New York
Chrono Therapeutics Top Executive David Happel Joins Cognoa as CEO 03/24/20 San Francisco
CytomX Taps Ex-Alder Bio Exec Campoy as Chief Financial Officer 03/24/20 San Francisco
CytomX Lands $80M to Kick Off Cancer Drug R&D Pact With Astellas 03/24/20 San Francisco
Palforzia Peanut Allergy Immunotherapy: Aimmune CEO on REMS, Manufacturing 03/24/20 National
Genprex Adds Chief Strategy Officer, Chief Operating Officer to C-Suite 03/23/20 Texas
Epizyme Names Infinity’s Jeffery Kutok as Chief Scientific Officer 03/23/20 Boston
Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown 03/23/20 National
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes 03/23/20 Europe
Keros Outlines IPO Plans Amid Markets Rocked by Coronavirus Pandemic 03/23/20 Boston
GSK Veteran Paul Wren Joins Escape Bio as Chief Scientific Officer 03/23/20 San Francisco
Emulate Taps PerkinElmer’s Corbett as CEO, Gets Cash for Commercial Push 03/23/20 Boston
UCSD, 5 Diagnostic Makers Partner to Ramp COVID-19 Testing Capacity 03/20/20 San Diego
Bio Roundup: Coronavirus Diagnostics, Therapeutics, Vaccines & More 03/20/20 National
Eureka Partners With Lyell to Tackle Tricky Solid Tumor Cell Therapies 03/20/20 San Francisco
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future 03/19/20 Boston
How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns 03/19/20 San Diego
Fears Of Recession Mount As Coronavirus Declared A Pandemic 03/19/20 National
Morphic Appoints Acceleron’s Peter Linde as Its Chief Medical Officer 03/18/20 Boston
Page 1 of 2125 next page »